Seeing Is Believing
Healthcare - Sector
NGM Biopharmaceuticals's activity chart (see below) currently has 68 price targets and 69 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.73% with an average time for these price targets to be met of 167 days.
Most recent stock forecast was given by from CANTOR FITZGERALD on 12-Mar-2024. First documented stock forecast 29-Apr-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2020
$6
Buy Since 30-Mar-2023
$1.55
$0.01 (0.65%)
Buy Since 29-Apr-2019
$1.55
$0.01 (0.65%)
Buy Since 27-Feb-2024
$1.55
$0.01 (0.65%)
Buy Since 17-Oct-2019
$3.5
$1.96 (127.27%)
$7
What is NGM (NGM Biopharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NGM (NGM Biopharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most bullish on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most reserved on NGM (NGM Biopharmaceuticals)?